Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ebola”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04041570
What this trial is testing

Ebola Sudan Chimpanzee Adenovirus Vector Vaccine in Healthy Adults

Who this might be right for
Ebola Virus
National Institute of Allergy and Infectious Diseases (NIAID) 40
Large-scale testing (Phase 3)Looking for participantsNCT06126822
What this trial is testing

Safety and Immunogenicity of Ervebo® and Zabdeno® Booster Vaccines Against Ebola Virus Following Previous Vaccination with the Zabdeno/Mvabea® or Ervebo® Vaccine Schedules in DRC

Who this might be right for
Ebola Virus Disease
Institute of Tropical Medicine, Belgium 624
Large-scale testing (Phase 3)Study completedNCT02378753
What this trial is testing

STRIVE (Sierra Leone Trial to Introduce a Vaccine Against Ebola)

Who this might be right for
Hemorrhagic Fever, Ebola
Centers for Disease Control and Prevention 8,651
Testing effectiveness (Phase 2)Study completedNCT05130398
What this trial is testing

Safety and Immunogenicity of the rVSVΔG-ZEBOV-GP Ebola Virus Vaccine Candidate in Children Living in Lambaréné, Gabon

Who this might be right for
Ebola Virus Disease
Centre de Recherche Médicale de Lambaréné 120
Testing effectiveness (Phase 2)Study completedNCT05284097
What this trial is testing

Ad26.ZEBOV, MVA-BN-Filo Vaccination in Children and Adults Previously Vaccinated With Control in the EBOVAC-Salone Study

Who this might be right for
Virus DiseasesHemorrhagic Fever, EbolaInfections+8 more
London School of Hygiene and Tropical Medicine 133
Testing effectiveness (Phase 2)Study completedNCT02598388
What this trial is testing

Safety, Tolerability and Immunogenicity Study of 2-dose Heterologous Regimens for Ebola Vaccines Ad26.ZEBOV/MVA-BN-Filo

Who this might be right for
Hemorrhagic Fever, Ebola
Janssen Vaccines & Prevention B.V. 578
Large-scale testing (Phase 3)Study completedNCT02342171
What this trial is testing

Emergency Evaluation of Convalescent Plasma for Ebola Viral Disease (EVD) in Guinea

Who this might be right for
Hemorrhagic Fever, Ebola
Institute of Tropical Medicine, Belgium 606
Testing effectiveness (Phase 2)Study completedNCT04385719
What this trial is testing

Drug-drug Interactions Between Remdesivir and Commonly Used Antiretroviral Therapy

Who this might be right for
EbolaHIV/AIDS
Makerere University 24
Large-scale testing (Phase 3)Study completedNCT04228783
What this trial is testing

2-dose Vaccine Regimen Using 3 Consecutive Lots of Ad26.ZEBOV and MVA-BN-Filo in Adult Participants

Who this might be right for
Ebola
Janssen Vaccines & Prevention B.V. 974
Early research (Phase 1)Study completedNCT02401373
What this trial is testing

A Phase I Trial to Evaluate Ad5-EBOV in Healthy Adult Africans in China.

Who this might be right for
Ebola Virus Disease
First Affiliated Hospital of Zhejiang University 61
Early research (Phase 1)Study completedNCT03478891
What this trial is testing

Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-EBOMAB092-00-AB (MAb114), Administered Intravenously to Healthy Adults

Who this might be right for
Healthy Adult Immune Responses to Vaccine
National Institute of Allergy and Infectious Diseases (NIAID) 19
Large-scale testing (Phase 3)Study completedNCT02543268
What this trial is testing

Evaluate the Immunogenicity, Safety and Tolerability of Ad26.ZEBOV and MVA-BN-Filo in Healthy Adult Participants

Who this might be right for
Healthy
Crucell Holland BV 329
Not applicableAvailableNCT03576690
What this trial is testing

R3470-3471-3479 (REGN-EB3) Expanded Access Protocol (EAP) for Treatment of Ebola Virus Disease

Who this might be right for
Ebola Virus Disease
Regeneron Pharmaceuticals
Not applicableStudy completedNCT02933931
What this trial is testing

Immune Durability After VSV-EBOV Vaccination

Who this might be right for
Immune ResponseVaccinationDurability
University Hospital, Geneva 95
Post-approval studies (Phase 4)Active Not RecruitingNCT05992480
What this trial is testing

REVIVE (Response to the Ebola Virus Vaccine)

Who this might be right for
Ebola Virus Disease
Tulane University 40
Testing effectiveness (Phase 2)Study completedNCT02788227
What this trial is testing

Immunogenicity of Recombinant Vesicular Stomatitis Vaccine for Ebola-Zaire (rVSV∆G-ZEBOV-GP Vaccine)

Who this might be right for
Healthy Volunteers
National Institutes of Health Clinical Center (CC) 248
Not applicableStudy completedNCT03820739
What this trial is testing

EBOVAC-Salone Extension

Who this might be right for
Ebola Virus Disease
London School of Hygiene and Tropical Medicine 653
Large-scale testing (Phase 3)Not Yet RecruitingNCT06841614
What this trial is testing

EBOla Post-Exposure Prophylaxis

Who this might be right for
Ebola Virus Disease
ANRS, Emerging Infectious Diseases 160
Early research (Phase 1)Study completedNCT02368119
What this trial is testing

Ebola CVD-Mali #2000 (Bivalent) VRC-EBOAdc069-00-vp (cAd3-EBO)

Who this might be right for
Ebola Virus DiseaseHemorrhagic Fever
University of Maryland, Baltimore 60
Early research (Phase 1)Ended earlyNCT03462004
What this trial is testing

Evaluating the Live-Attenuated Human Parainfluenza Virus Type 3 Vectored Vaccine Candidate Expressing Ebolavirus Zaire Glycoprotein as the Sole Envelope Glycoprotein

Who this might be right for
Ebola Virus Disease
National Institute of Allergy and Infectious Diseases (NIAID) 15
Next Page